| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |